Article
Senolytics restore hematopoietic stem cell function in sickle cell disease
2025-02-09
Abstract excerpt
Sickle Cell Disease (SCD) is a blood disorder affecting millions worldwide. Emerging evidence reveals that SCD pathophysiology increases risk of myeloid malignancies and hematopoietic stem cell (HSC) dysfunction, possibly due to pathological stress on bone marrow. To investigate this further, we interrogated mice and individuals with SCD and observed extended cell cycle times, oxidative stress, DNA damage, senesce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a334ff1f-e23e-59a2-8e37-ec0c60b001a9
- DOI
- 10.1101/2025.02.08.636742
